Ludivine Morisset (Ludivine Morriset)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Cell Cycle Arrest

Breast Cancer Cells

Endoplasmic Reticulum

Estrogen Receptor

Top Venues

Science translational medicine

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Marina Bacci, Nicla Lorito, Alfredo Smiriglia, Angela Subbiani, Francesca Bonechi, Giuseppina Comito, Ludivine Morisset, Rania El-Botty, Matteo Benelli, Joanna I López-Velazco, María M Caffarel, Ander Urruticoechea, George Sflomos, Luca Malorni, Michela Corsini, Luigi Ippolito, Elisa Giannoni, Icro Meattini, Vittoria Matafora, Kristina M Havas, Angela Bachi, Paola Chiarugi, Elisabetta Marangoni, Andrea Morandi
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER + breast cancer. Science translational medicine 16 (736) (2024)
Marina Bacci, Nicla Lorito, Alfredo Smiriglia, Angela Subbiani, Francesca Bonechi, Giuseppina Comito, Ludivine Morisset, Rania El-Botty, Matteo Benelli, Joanna I López-Velazco, María M Caffarel, Ander Urruticoechea, George Sflomos, Luca Malorni, Michela Corsini, Luigi Ippolito, Elisa Giannoni, Icro Meattini, Vittoria Matafora, Kristina M Havas, Angela Bachi, Paola Chiarugi, Elisabetta Marangoni, Andrea Morandi
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER + breast cancer. Science translational medicine 16 (736) (2024)
Arany Soosainathan, Marjan Iravani, Rania El-Botty, John Alexander, Laura Sourd, Ludivine Morisset, Pierre Painsec, Rebecca Orha, Joanna Nikitorowicz-Buniak, Sunil Pancholi, Syed Haider, Mitchell Dowsett, Elisabetta Marangoni, Lesley-Ann Martin, Clare M Isacke
Targeting transcriptional regulation with a CDK9 inhibitor suppresses growth of endocrine- and palbociclib-resistant ER+ breast cancers. Cancer research (2023)